Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Pharmaceutical dealmaking slowed during the first half of 2026, yet industry experts say transaction quality has become more important than volume. Speaking with Pharmaceutical Technology, KPMG US Life Sciences Sector Leader Kristin Ciriello Pothier explained that manufacturers now place greater
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended Eli Lilly’s Jaypirca (pirtobrutinib) for approval to treat adults with chronic lymphocytic leukemia (CLL) across all lines of therapy, regardless of previous BTK inhibitor treatment. The
This article explains the evolving role of a GMP Quality Manager in pharmaceutical operations, focusing on quality system ownership, CAPA management, deviation investigations, and FDA inspection readiness. It highlights key competencies required for effective pharmaceutical quality management systems today.
This article explains how QMS Implementation in 2026 strengthens GMP inspection readiness by improving CAPA effectiveness, data integrity compliance, and change control management. It also highlights how pharmaceutical quality systems reduce FDA inspection findings and ensure regulatory compliance stability across
This article explores the pharma quality management system, focusing on GMP compliance frameworks, quality risk management, CAPA effectiveness, and data integrity. It explains how modern pharmaceutical organizations build resilient quality systems to ensure inspection readiness and regulatory performance in highly
This article explains the regulatory relationship between CMC and GMP, highlighting key differences, inspection findings, and compliance expectations. It shows how documentation, validation, and manufacturing control connect to FDA and global pharmaceutical quality system requirements.
Pharmaceutical supply chain roles now carry direct regulatory and commercial impact. This article examines how demand, salaries, and career paths evolve across regulated logistics, distribution, and global supply networks, helping professionals understand where hiring pressure concentrates and why compensation continues
Pharmaceutical supply chain companies play a critical role in compliant sourcing, storage, and global distribution. This article explores how pharma logistics companies manage cold chain control, regulatory expectations, and complex pharmaceutical distribution networks across highly regulated healthcare markets.
GMP inspections frequently identify facility and environmental control weaknesses as root causes of compliance risk. This article examines how cleanroom standards, layout decisions, and documentation influence contamination control, inspection readiness, and regulatory expectations across pharmaceutical manufacturing environments.